Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 3Sarcoma 1Lymphoid 1Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 51Lymphoma 49Burkitt Lymphoma 33Leukemia 29Lymphoma, Non-Hodgkin 19Lymphoma, Large B-Cell, Diffuse 13Lymphoma, Mantle-Cell 10Leukemia, Biphenotypic, Acute 10Leukemia, Myeloid, Acute 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Large-Cell, Immunoblastic 8Hodgkin Disease 8Myelodysplastic Syndromes 7Lymphoma, Large-Cell, Anaplastic 7Lymphoma, Follicular 7Leukemia, Lymphocytic, Chronic, B-Cell 7Dendritic Cell Sarcoma, Interdigitating 7Leukemia, Myelomonocytic, Chronic 6Multiple Myeloma 5Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms, Plasma Cell 4Myeloproliferative Disorders 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4HIV Infections 4Blast Crisis 4Acquired Immunodeficiency Syndrome 4Recurrence 3Primary Myelofibrosis 3

Interventions

Radiotherapy 2glucarpidase 1apraglutide 1angiotensin I (1-7) 1Methotrexate 1Leucovorin 1Gelclair 1Drug Therapy 12-(3',4'-dihydroxyphenyl-1-azo)benzimidazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mucositis × Leucovorin × Lymphoid × Clear all
NCT00727831 2014-01-27

Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

University College, London

Phase 1/2 Completed
4 enrolled
LymphoidOther

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Neurotoxicity Syndromes, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡